Given the ability of WISP1 to control cellular proliferation in the musculoskeletal system, WISP1 and related members of the CCN family have emerged as potential targets for disorders such as osteoarthritis and rheumatoid arthritis. This evidence concerns the gene CCN4 and osteoarthritis.